The neural dust platform from iota is powered by ultrasound, enabling the company to produce devices the size of a grain of sand that avoid the dangers associated with wire- and battery-powered implantables.
Because they are smaller and can be implanted deeper into the human body than traditional technologies, neural dust can interface directly with specific nerve clusters, enabling more precise diagnostics and treatments.
The company’s devices can simultaneously record information and stimulate nerves, offering near instantaneous closed-loop therapies that could better treat complex disease from the inside out, said Michel M. Maharbiz, co-CEO and founder at iota.
